|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0076 | ED148592 | General Research Use | No | Female | White | 65 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0238 | ED148796 | General Research Use | No | Male | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_0243 | ED148388 | General Research Use | No | Female | White | 64 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0251 | ED148723 | General Research Use | No | Male | White | 83 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0300 | ED148558 | General Research Use | No | Female | White | 65 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0348 | ED148850 | General Research Use | No | Male | White | 71 | 6 - AREDS AMD Severity Scale Step 2 | 10 - Central GA |
| AR2_0362 | ED149681 | General Research Use | No | Male | White | 78 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0370 | ED148404 | General Research Use | No | Male | White | 79 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0382 | ED149331 | General Research Use | No | Female | White | 52 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0406 | ED149918 | General Research Use | No | Female | White | 68 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0407 | ED149642 | General Research Use | No | Female | White | 78 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0468 | ED148507 | Eye Disease Only | No | Female | White | 69 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0645 | ED148892 | General Research Use | No | Female | White | 83 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0682 | ED148561 | General Research Use | No | Female | White | 76 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0703 | ED149949 | General Research Use | No | Female | White | 76 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0751 | ED149396 | General Research Use | No | Female | White | 84 | 6 - AREDS AMD Severity Scale Step 5 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0757 | ED148835 | General Research Use | No | Female | White | 73 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0776 | ED148987 | General Research Use | No | Female | White | 78 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0844 | ED148569 | General Research Use | No | Female | White | 74 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0861 | ED148308 | General Research Use | No | Female | White | 82 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |